Differentiating Chronic Rhinosinusitis from Other Headache Disorders

Chronic rhinosinusitis is a condition characterized by inflammation of the paranasal sinuses and nasal passages that lasts for 12 weeks or longer. Patients with chronic rhinosinusitis typically present with symptoms such as nasal congestion, coughing, persistent headache that worsens on bending forwards, facial pain, nasal discharge, and postnasal drip. Predisposing factors for chronic rhinosinusitis include atopy, nasal obstruction, recent local infection, swimming or diving, and smoking. Management of chronic rhinosinusitis involves avoidance of allergens, intranasal corticosteroids, and nasal irrigation with saline.

Acute sinusitis shares many features with chronic rhinosinusitis, but the history of symptoms is much shorter. Treatment for acute sinusitis includes analgesia, intranasal decongestants or nasal saline, and intranasal corticosteroids if symptoms persist for more than ten days. Oral antibiotics may be given for severe presentations.

Cluster headaches are characterized by intense, sharp, stabbing pain around one eye, accompanied by eye redness, lacrimation, lid swelling, nasal stuffiness, skin erythema, miosis or ptosis. Cluster headaches occur in clusters lasting between four and 12 weeks, with patients feeling completely fine in between clusters. Tension headaches are described as a band-like headache that does not impair activities of daily living.

Postnasal drip (PND) typically presents with a chronic cough and bad breath, unlike the presentation in chronic rhinosinusitis. It is important to differentiate chronic rhinosinusitis from other headache disorders to ensure appropriate management and treatment.

Understanding Lichen Planus

Lichen planus is a skin condition that is believed to be caused by an immune response, although the exact cause is unknown. It is characterized by an itchy, papular rash that typically appears on the palms, soles, genitalia, and flexor surfaces of the arms. The rash often has a polygonal shape and a distinctive white-lines pattern on the surface, known as Wickham’s striae. In some cases, new skin lesions may appear at the site of trauma, a phenomenon known as the Koebner phenomenon.

Oral involvement is common in around 50% of patients, with a white-lace pattern often appearing on the buccal mucosa. Nail changes may also occur, including thinning of the nail plate and longitudinal ridging. Lichenoid drug eruptions can be caused by certain medications, such as gold, quinine, and thiazides.

The main treatment for lichen planus is potent topical steroids. For oral lichen planus, benzydamine mouthwash or spray is recommended. In more extensive cases, oral steroids or immunosuppression may be necessary.

Managing Treatment for Pregnant Patients with Autoimmune Diseases

When treating pregnant patients with autoimmune diseases, it is important to consider the potential risks and benefits of different medications. In the case of a patient already on an established dose of azathioprine, it is generally recommended to continue this medication during pregnancy, as stopping or reducing the dose could put the patient at risk of disease progression. Methotrexate should never be used during pregnancy due to its teratogenic effects. High-dose corticosteroids may also pose risks to the developing fetus if used for prolonged periods. Stopping all treatment could trigger disease worsening, so it is important to carefully weigh the risks and benefits of any changes to medication. In some cases, infliximab may be necessary during pregnancy, but this should be carefully considered and discussed with a specialist. Overall, managing treatment for pregnant patients with autoimmune diseases requires careful consideration of the potential risks and benefits of different medications.

The recommended approach for managing Achilles tendonitis is to advise the patient to rest, take NSAIDs, and seek physiotherapy if symptoms persist beyond 7 days. However, it is important to note that ibuprofen should be avoided in patients with asthma. Simply reiterating the need for rest may not address the patient’s desire for more aggressive treatment options. Referring the patient to orthopaedics would not be appropriate, but a referral to rheumatology may be considered if the symptoms do not improve. While steroids may provide some benefit, the evidence is mixed and injecting them directly into the tendon can increase the risk of tendon rupture.

Achilles tendon disorders are a common cause of pain in the back of the heel. These disorders can include tendinopathy, partial tears, and complete ruptures of the Achilles tendon. Certain factors, such as the use of quinolone antibiotics and high cholesterol levels, can increase the risk of developing these disorders. Symptoms of Achilles tendinopathy typically include gradual onset of pain that worsens with activity, as well as morning stiffness. Treatment for this condition usually involves pain relief, reducing activities that exacerbate the pain, and performing calf muscle eccentric exercises.

In contrast, an Achilles tendon rupture is a more serious condition that requires immediate medical attention. This type of injury is often caused by sudden, forceful movements during sports or running. Symptoms of an Achilles tendon rupture include an audible popping sound, sudden and severe pain in the calf or ankle, and an inability to walk or continue the activity. To help diagnose an Achilles tendon rupture, doctors may use Simmond’s triad, which involves examining the foot for abnormal angles and feeling for a gap in the tendon. Ultrasound is typically the first imaging test used to confirm a diagnosis of Achilles tendon rupture. If a rupture is suspected, it is important to seek medical attention from an orthopaedic specialist as soon as possible.

Pre-menopausal women with oestrogen receptor-positive breast cancer are managed using Tamoxifen.
Tamoxifen is ineffective in treating oestrogen receptor-negative breast cancer or ovarian cancer.
However, Tamoxifen may increase the risk of endometrial cancer.
Colorectal cancer is not treated with Tamoxifen.

Anti-oestrogen drugs are used in the management of oestrogen receptor-positive breast cancer. Selective oEstrogen Receptor Modulators (SERM) such as Tamoxifen act as an oestrogen receptor antagonist and partial agonist. However, Tamoxifen can cause adverse effects such as menstrual disturbance, hot flushes, venous thromboembolism, and endometrial cancer. On the other hand, aromatase inhibitors like Anastrozole and Letrozole reduce peripheral oestrogen synthesis, which is important in postmenopausal women. Anastrozole is used for ER +ve breast cancer in this group. However, aromatase inhibitors can cause adverse effects such as osteoporosis, hot flushes, arthralgia, myalgia, and insomnia. NICE recommends a DEXA scan when initiating a patient on aromatase inhibitors for breast cancer.

Patients who are on long-term steroids or methotrexate and are immunosuppressed should be given VZIG if they are exposed to chickenpox and have no antibodies to varicella. The correct course of action is to conduct antibody testing to determine if the patient is negative, and if so, administer VZIG to protect them from potentially developing a serious chickenpox infection. Although a chickenpox vaccine exists, it is not part of the routine childhood vaccination schedule and is not recommended for immunosuppressed individuals due to its live nature. IV aciclovir can be given for chickenpox infection in immunocompromised individuals, but VZIG is more appropriate as it can help prevent the infection from manifesting. Administering VZIG once the patient has already shown symptoms of chickenpox is too late, as it has no therapeutic benefit at that point. While oral aciclovir can be given prophylactically or to reduce the severity of symptoms, VZIG is more appropriate for immunosuppressed patients who are at high risk of severe chickenpox infection.

Managing Chickenpox Exposure in At-Risk Groups

Chickenpox is usually a mild illness in children with normal immune systems, but it can cause serious systemic disease in at-risk groups. Pregnant women and their developing fetuses are particularly vulnerable. Therefore, it is crucial to know how to manage varicella exposure in these special groups.

To determine who would benefit from active post-exposure prophylaxis, three criteria should be met. Firstly, there must be significant exposure to chickenpox or herpes zoster. Secondly, the patient must have a clinical condition that increases the risk of severe varicella, such as immunosuppression, neonates, or pregnancy. Finally, the patient should have no antibodies to the varicella virus. Ideally, all at-risk exposed patients should have a blood test for varicella antibodies. However, this should not delay post-exposure prophylaxis past seven days after initial contact.

Patients who meet the above criteria should be given varicella-zoster immunoglobulin (VZIG). Managing chickenpox exposure in pregnancy is an important topic that requires more detailed discussion, which is covered in a separate entry in the textbook.

Choosing the Right Treatment for Hypoglycaemic Episodes in Type 2 Diabetes

When metformin alone is not enough to control HbA1c in type 2 diabetes, NICE recommends adding a sulfonylurea, pioglitazone, or a DPP-4 inhibitor. However, if the patient experiences hypoglycaemic episodes, it is important to reassess the treatment plan.

Stopping gliclazide, a sulfonylurea, is necessary as it is likely causing the hypoglycaemic episodes. Pioglitazone is contraindicated in patients with heart failure, so a DPP-4 inhibitor like sitagliptin is the appropriate next step.

Initiating insulin is not recommended as it can be dangerous, and should only be considered after other options have failed. Reducing metformin is unlikely to prevent hypoglycaemic episodes as it does not typically cause them on its own.

In summary, choosing the right treatment for hypoglycaemic episodes in type 2 diabetes involves careful consideration of the patient’s medical history and NICE guidelines.

Treatment of Diabetic Ketoacidosis: Continuing Long-Acting Insulin and Stopping Short-Acting Insulin

When a patient presents with diabetic ketoacidosis (DKA), it is important to provide prompt treatment. This involves fluid replacement with isotonic saline and an intravenous insulin infusion at 0.1 unit/kg per hour. While this takes place, the patient’s normal long-acting insulin should be continued, but their short-acting insulin should be stopped to avoid hypoglycemia.

In addition to insulin and fluid replacement, correction of electrolyte disturbance is essential. Serum potassium levels may be high on admission, but often fall quickly following treatment with insulin, resulting in hypokalemia. Potassium may need to be added to the replacement fluids, guided by the potassium levels. If the rate of potassium infusion is greater than 20 mmol/hour, cardiac monitoring is required.

Overall, the key to successful treatment of DKA is a careful balance of insulin, fluids, and electrolyte replacement. By continuing long-acting insulin and stopping short-acting insulin, healthcare providers can help ensure the best possible outcome for their patients.

Saxagliptin: A DPP-4 Inhibitor for Type 2 Diabetes Treatment

Saxagliptin is an oral hypoglycaemic drug that belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Its mechanism of action involves slowing down the breakdown of incretin hormones, which stimulates insulin production and reduces gluconeogenesis in the liver. Compared to sitagliptin, saxagliptin has a shorter half-life. It is safe to use in patients with mild to moderate renal impairment, but should be avoided in severe cases. Saxagliptin is recommended as first-line therapy for type 2 diabetes in combination with other drugs or as initial monotherapy if metformin is contraindicated or not tolerated. However, its use during pregnancy and breastfeeding should be avoided due to potential toxicity. Regular monitoring of renal function is necessary before and during saxagliptin treatment.

Azathioprine is a medication that is broken down into mercaptopurine, which is an active compound that inhibits the production of purine. To determine if someone is at risk for azathioprine toxicity, a test for thiopurine methyltransferase (TPMT) may be necessary. Adverse effects of this medication include bone marrow depression, which can be detected through a full blood count if there are signs of infection or bleeding, as well as nausea, vomiting, pancreatitis, and an increased risk of non-melanoma skin cancer. It is important to note that there is a significant interaction between azathioprine and allopurinol, so lower doses of azathioprine should be used in conjunction with allopurinol. Despite these potential side effects, azathioprine is generally considered safe to use during pregnancy.

Risks of Smoking, Alcohol, and Illegal Drugs During Pregnancy

During pregnancy, drug use can have serious consequences for both the mother and the developing fetus. Smoking during pregnancy increases the risk of miscarriage, pre-term labor, stillbirth, and sudden unexpected death in infancy. Alcohol consumption can lead to fetal alcohol syndrome, which can cause learning difficulties, characteristic facial features, and growth restrictions. Binge drinking is a major risk factor for fetal alcohol syndrome. Cannabis use poses similar risks to smoking due to the tobacco content. Cocaine use can lead to hypertension in pregnancy, including pre-eclampsia, and placental abruption. Fetal risks include prematurity and neonatal abstinence syndrome. Heroin use can result in neonatal abstinence syndrome. It is important for pregnant women to avoid drug use to ensure the health and well-being of both themselves and their unborn child.

The TFTs indicate a diagnosis of hypothyroidism, which can be treated with levothyroxine. Carbimazole is not suitable for this condition as it is used to treat hyperthyroidism. To ensure proper absorption, levothyroxine should be taken 30 minutes before consuming food, caffeine, or other medications.

Managing Hypothyroidism: Dosage, Monitoring, and Side-Effects

Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormone. The main treatment for hypothyroidism is levothyroxine, a synthetic form of thyroid hormone. When managing hypothyroidism, it is important to consider the patient’s age, cardiac history, and initial starting dose. Elderly patients and those with ischaemic heart disease should start with a lower dose of 25mcg od, while other patients can start with 50-100mcg od. After a change in dosage, thyroid function tests should be checked after 8-12 weeks to ensure the therapeutic goal of normalising the thyroid stimulating hormone (TSH) level is achieved. The target TSH range is 0.5-2.5 mU/l.

Women with hypothyroidism who become pregnant should have their dose increased by at least 25-50 micrograms levothyroxine due to the increased demands of pregnancy. The TSH should be monitored carefully, aiming for a low-normal value. It is important to note that there is no evidence to support combination therapy with levothyroxine and liothyronine.

While levothyroxine is generally well-tolerated, there are some potential side-effects to be aware of. Over-treatment can lead to hyperthyroidism, while long-term use can reduce bone mineral density. In patients with cardiac disease, levothyroxine can worsen angina and lead to atrial fibrillation. It is also important to be aware of drug interactions, particularly with iron and calcium carbonate, which can reduce the absorption of levothyroxine. These medications should be given at least 4 hours apart.

In summary, managing hypothyroidism involves careful consideration of dosage, monitoring of TSH levels, and awareness of potential side-effects and drug interactions. With appropriate management, patients with hypothyroidism can achieve normal thyroid function and improve their overall health.

Understanding Prolapsed Disc and its Features

A prolapsed lumbar disc is a common cause of lower back pain that can lead to neurological deficits. It is characterized by clear dermatomal leg pain, which is usually worse than the back pain. The pain is often aggravated when sitting. The features of the prolapsed disc depend on the site of compression. For instance, L3 nerve root compression can cause sensory loss over the anterior thigh, weak quadriceps, reduced knee reflex, and a positive femoral stretch test. On the other hand, L4 nerve root compression can lead to sensory loss in the anterior aspect of the knee, weak quadriceps, reduced knee reflex, and a positive femoral stretch test.

The management of prolapsed disc is similar to that of other musculoskeletal lower back pain. It involves analgesia, physiotherapy, and exercises. According to NICE, the first-line treatment for back pain without sciatica symptoms is NSAIDs +/- proton pump inhibitors, rather than neuropathic analgesia. If the symptoms persist after 4-6 weeks, referral for consideration of MRI is appropriate. Understanding the features of prolapsed disc can help in the diagnosis and management of this condition.

Contraceptives – Time to become effective (if not used on the first day of period):
Immediate: IUD
2 days: Progestin-only pill (POP)
7 days: Combined oral contraceptive (COC), injection, implant, intrauterine system (IUS)

Intrauterine contraceptive devices include copper IUDs and levonorgestrel-releasing IUS. Both are over 99% effective. The IUD prevents fertilization by decreasing sperm motility, while the IUS prevents endometrial proliferation and thickens cervical mucus. Potential problems include heavier periods with IUDs and initial bleeding with the IUS. There is a small risk of uterine perforation, ectopic pregnancy, and infection. New IUS systems, such as Jaydess® and Kyleena®, have smaller frames and less levonorgestrel, resulting in lower serum levels and different rates of amenorrhea.

Phenytoin: Mechanism of Action and Adverse Effects

Phenytoin is a medication used to manage seizures. Its mechanism of action involves binding to sodium channels, which increases their refractory period. However, the drug is associated with a large number of adverse effects, which can be categorized as acute, chronic, idiosyncratic, and teratogenic. Acute effects include dizziness, diplopia, nystagmus, slurred speech, ataxia, confusion, and seizures. Chronic effects include gingival hyperplasia, hirsutism, coarsening of facial features, drowsiness, megaloblastic anemia, peripheral neuropathy, enhanced vitamin D metabolism causing osteomalacia, lymphadenopathy, and dyskinesia. Idiosyncratic effects include fever, rashes, hepatitis, Dupuytren’s contracture, aplastic anemia, and drug-induced lupus. Teratogenic effects are associated with cleft palate and congenital heart disease. Although routine monitoring of phenytoin levels is not necessary, trough levels should be checked before dosing in cases of dose adjustment, suspected toxicity, or non-adherence to the prescribed medication.

Differential Diagnosis of Seizures in Children: A Case Study

A child presents with a seizure following a fever. The differential diagnosis includes febrile convulsion, myoclonic epilepsy, bacterial meningitis, viral encephalitis, and generalised epilepsy syndrome. However, the absence of intracranial infection and other neurological features suggests that febrile convulsion is the most likely diagnosis. Febrile convulsions are common in children aged 3 months to 5 years and are associated with viral illnesses. They are generalised, last less than 15 minutes, and do not recur within 24 hours. Children with febrile seizures have no increased mortality risk but may have a slightly increased risk of epilepsy in later life. Other possible causes of seizures, such as breath-holding attacks or reflex anoxic seizures, should also be considered. Education on managing fevers and keeping the child comfortable during illnesses should be provided to the family.

Premature Ovarian Insufficiency: Causes and Management

Premature ovarian insufficiency is a condition where menopausal symptoms and elevated gonadotrophin levels occur before the age of 40. It affects approximately 1 in 100 women and can be caused by various factors such as idiopathic reasons, family history, bilateral oophorectomy, radiotherapy, chemotherapy, infection, autoimmune disorders, and resistant ovary syndrome. The symptoms of premature ovarian insufficiency are similar to those of normal menopause, including hot flushes, night sweats, infertility, secondary amenorrhoea, raised FSH and LH levels, and low oestradiol.

Management of premature ovarian insufficiency involves hormone replacement therapy (HRT) or a combined oral contraceptive pill until the age of the average menopause, which is 51 years. It is important to note that HRT does not provide contraception in case spontaneous ovarian activity resumes. Early diagnosis and management of premature ovarian insufficiency can help alleviate symptoms and improve quality of life for affected women.

Lynch syndrome is a genetic condition that increases the risk of developing colorectal cancer by over 80%. It also raises the risk of other cancers such as endometrial, stomach, breast, ovarian, small bowel, pancreatic, prostate, urinary tract, kidney, and liver cancer. Genetic testing is recommended for anyone diagnosed with colorectal cancer, regardless of age.

Breast cancer (BRCA) mutations are inherited in an autosomal dominant pattern and significantly increase the risk of developing breast, ovarian, prostate, and pancreatic cancer. These cancers tend to occur at a younger age than in the general population. While there is a possible link to colorectal pathology, other genetic syndromes should be considered first when looking for a genetic cause of cancer.

Cowden syndrome is a rare genetic condition characterized by benign growths called hamartomas on various parts of the body. It increases the risk of developing breast, thyroid, or endometrial cancer but has no association with colorectal cancer.

Familial adenomatous polyposis is an autosomal dominant condition that causes widespread colorectal adenomas, with polyps usually developing in late childhood. This greatly increases the risk of colorectal cancer, and prophylactic colectomy is often performed. Screening is recommended for those with an affected first-degree relative or multiple polyps detected on colonoscopy.

Von Hippel-Landau (VHL) syndrome is an autosomal dominant condition that causes multiple benign tumors and cysts in various parts of the body, including the brain, spinal cord, eyes, adrenals, kidneys, and pancreas. It increases the risk of renal and pancreatic cancer but has no association with colorectal cancer.

Patients with hypokalaemia are more likely to experience digoxin toxicity.

Understanding Digoxin and Its Toxicity

Digoxin is a medication used for rate control in atrial fibrillation and for improving symptoms in heart failure patients. It works by decreasing conduction through the atrioventricular node and increasing the force of cardiac muscle contraction. However, it has a narrow therapeutic index and requires monitoring for toxicity.

Toxicity may occur even when the digoxin concentration is within the therapeutic range. Symptoms of toxicity include lethargy, nausea, vomiting, anorexia, confusion, yellow-green vision, arrhythmias, and gynaecomastia. Hypokalaemia is a classic precipitating factor, as it allows digoxin to more easily bind to the ATPase pump and increase its inhibitory effects. Other factors that may contribute to toxicity include increasing age, renal failure, myocardial ischaemia, electrolyte imbalances, hypoalbuminaemia, hypothermia, hypothyroidism, and certain medications such as amiodarone, quinidine, and verapamil.

Management of digoxin toxicity involves the use of Digibind, correction of arrhythmias, and monitoring of potassium levels. It is important to recognize the potential for toxicity and monitor patients accordingly to prevent adverse outcomes.

Lumbar spinal canal stenosis is often indicated by a history of progressive painful neurological deficit that improves when resting or leaning forward. This condition causes nerve root ischaemia due to inadequate microvascular blood flow to the spinal nerve roots, resulting in bilateral neuropathic pain and progressive deficit affecting the dermatomes and myotomes below the affected level. Leaning forward widens the canal, providing relief, while resting reduces the oxygen requirement of the nerve roots, allowing the ischaemia to slowly resolve. Neurological examination of the legs usually shows no abnormal findings as the symptoms are only brought on by consistent use of the nerve roots.

Osteoarthritis, on the other hand, is a degenerative arthropathy that typically affects large weight-bearing joints in the lower limbs, causing pain that rarely improves with rest and is not associated with a neurological deficit. It is usually unilateral and does not cause symmetrical symptoms.

Peripheral neuropathy can produce similar symptoms to spinal stenosis, but the pathology is not related to nerve use, and a deficit (usually sensory) would be detected on examination. The absence of such findings indicates that peripheral neuropathy is not the cause.

Peripheral vascular disease is the most likely differential for patients with spinal stenosis and symptoms of progressive leg pain that is relieved by rest. However, evidence of vascular insufficiency, such as absent distal pulses, ulceration or skin changes, would be present on examination if the condition were severe enough to cause symptoms after relatively short distances of walking. Additionally, leaning forward does not improve symptoms in peripheral vascular disease, only rest does.

Lumbar spinal stenosis is a condition where the central canal in the lower back is narrowed due to degenerative changes, such as a tumor or disk prolapse. Patients may experience back pain, neuropathic pain, and symptoms similar to claudication. However, one distinguishing factor is that the pain is positional, with sitting being more comfortable than standing, and walking uphill being easier than downhill. Degenerative disease is the most common cause, starting with changes in the intervertebral disk that lead to disk bulging and collapse. This puts stress on the facet joints, causing cartilage degeneration, hypertrophy, and osteophyte formation, which narrows the spinal canal and compresses the nerve roots of the cauda equina. MRI scanning is the best way to diagnose lumbar spinal stenosis, and treatment may involve a laminectomy.

Overall, lumbar spinal stenosis is a condition that affects the lower back and can cause a range of symptoms, including pain and discomfort. It is often caused by degenerative changes in the intervertebral disk, which can lead to narrowing of the spinal canal and compression of the nerve roots. Diagnosis is typically done through MRI scanning, and treatment may involve a laminectomy. It is important to note that the pain associated with lumbar spinal stenosis is positional, with sitting being more comfortable than standing, and walking uphill being easier than downhill.